UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction | (Commission File Number) | (IRS Employer Identification No.) | ||
| of incorporation) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area
code:
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
| Item 2.02 | Results of Operations and Financial Condition. |
On May 13, 2022, AEye, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information provided in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
| Item 9.01. | Financial Statement and Exhibits. |
(d) Exhibits.
| Exhibit Number | Description |
| 99.1 | Press release dated May 13, 2022. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| 1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AEye, Inc. | |||
| Dated: May 13, 2022 | |||
| By: | /s/ Robert A. Brown | ||
| Robert A. Brown | |||
| Chief Financial Officer | |||
Exhibit 99.1
AEYE REPORTS FIRST QUARTER 2022 RESULTS
Strong Revenue Growth; On Track to Achieve 2022 Financial and Commercial Goals
Dublin, Calif.– May 13, 2022 — AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, today announced its results for the first quarter, ended March 31, 2022.
Blair LaCorte, Chief Executive Officer of AEye, said, “We had a strong start to the fiscal year, and made substantial progress toward commercial production. Our software-definable sensors are gaining traction in the marketplace as more and more customers recognize and adopt our revolutionary designs, which lead the industry in performance and adaptability.”
“While the industry continues to mitigate supply chain challenges and economic uncertainty, we remain well-positioned to navigate, innovate, and lead through the current disruptions. Our dedication and relentless focus on executing at a high level provides AEye with significant opportunity to strengthen our competitive position and deliver on our key objectives for 2022,” continued LaCorte.
Q1 2022 Financials
| · | AEye reported revenue of $1.1 million in the first quarter of 2022. |
| · | GAAP net loss was $(24.9) million in the first quarter of 2022, or $(0.16) per share based on 155.5 million weighted average shares outstanding. |
| · | Non-GAAP net loss was $(19.5) million in the first quarter of 2022, or $(0.13) per share based on 155.5 million weighted average shares outstanding. |
| · | Cash, cash equivalents, and marketable securities were $143.9 million as of March 31, 2022. This excludes $125 million in available liquidity from our Common Stock Purchase Agreement. |
Conference Call and Webcast Details
AEye management will hold a conference call today, May 13, 2022, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss these results. AEye CEO Blair LaCorte and CFO Bob Brown will host the call, followed by a question-and-answer session.
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
The call is also accessible via telephone through the following details:
Dial in Information:
| · | Participant Toll-Free Dial-In Number: 844-763-8274 |
| · | Participant International Dial-In Number: 412-717-9224 |
About AEye
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, logistics and off-highway applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most; delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has global presence through its offices in Germany, Japan, Korea, and the United States.
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to investors for a more consistent basis of comparison and to help investors evaluate the results of the Company’s on-going operations, and to help enable more meaningful period-to-period comparison. Non-GAAP financial measures are presented only as supplemental information for purposes of understanding the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.
This presentation includes non-GAAP financial measures, including:
| · | Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus change in fair value of embedded derivative and warrant liabilities |
| · | Adjusted EBITDA which is defined as non-GAAP net loss plus amortization and depreciation expense, plus interest expense and other, less interest income and other, plus provision for income tax expense. |
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about AEye’s products, the Company’s progress in commercialization, and the expected results for 2022, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability.
Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that AEye’s strong start to the fiscal year may not continued as anticipated; (ii) the risks the substantial progress toward commercial productionization may not continue as anticipated, or at all; (iii) the risks that the traction gained in the marketplace may not continue, or result in revenue for the Company in the timeframe expected; (iv) the risks that customer recongiztion and adoption of AEye’s products may not occur in the timeframe or quantity expected, or at all; (v) the risks that AEye’s products may not lead the industry in performance or adability in ways viewed to be appreciable in the marketplace; (vi) the risks that the Company may not be able to successfully navigate either or both of the supply chain challenges it faces or the macroeconomic uncertainty that exists; (vii) the risks that AEye will be unable to successfully innovate or lead through the current economic and supply chain disruption as it currently anticipates, or at all; (viii) the risks that AEye will be unable to capitalize on the opportunities created by the global economic uncertainties or supply chain challenges; (ix) the risks that AEye will be unable to strengthen its competitive position nor deliver on its key objectives in 2022 due to supply chain disruptions, economic uncertainites, or otherwise; (x) the risks that competing technologies will improve overtime to become operationally equivalent or more cost-effective, or both; (xi) the risks that competitors may introduce products with similar capabilities to AEye’s products and such competitive products take some or all of the market share away from AEye; (xii) the risks that AEye’s products will not meet the diverse range of performance and functional requirements of AEye’s target markets and customers; (xiii) the risks that AEye’s products will not function as anticipated by AEye or by AEye’s target markets and customers; (xiv) the risks that the size of the total available market for the use of lidar will be smaller than predicted or take longer to come to fruition than predicted; (xv) the risk that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xvi) changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xvii) the risk that AEye is unable to adequately implement its business plans, forecasts, and other expectations, and identify and realize additional opportunities, and (xviii) the risk of downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by the COVID-19 pandemic, including the Delta, Omicron, “Deltacron,” and future variants and subvariants, which has caused, and continue to cause, significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of AEye’s Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the “SEC”) and other documents filed by AEye or that will be filed by AEye from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.
Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.
| AEYE, INC. Condensed Consolidated Balance Sheets (In thousands) (Unaudited) | ||||||||
| March 31, 2022 | December 31, 2022 | |||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 11,177 | $ | 14,183 | ||||
| Marketable securities | 132,674 | 149,824 | ||||||
| Accounts receivable, net | 292 | 4,222 | ||||||
| Inventories, net | 4,254 | 4,085 | ||||||
| Prepaid and other current assets | 4,541 | 5,051 | ||||||
| Total current assets | 152,938 | 177,365 | ||||||
| Right-of-use assets | 15,968 | — | ||||||
| Property and equipment, net | 5,685 | 5,129 | ||||||
| Restricted cash | 2,150 | 2,150 | ||||||
| Other noncurrent assets | 1,109 | 1,509 | ||||||
| Total assets | $ | 177,850 | $ | 186,153 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable | $ | 1,952 | $ | 2,542 | ||||
| Accrued expenses and other current liabilities | 8,995 | 8,739 | ||||||
| Contract liabilities | 1,852 | 2,287 | ||||||
| Total current liabilities | 12,799 | 13,568 | ||||||
| Operating lease liabilities, noncurrent | 17,323 | — | ||||||
| Deferred rent, noncurrent | — | 3,032 | ||||||
| Other noncurrent liabilities | 485 | 786 | ||||||
| Total liabilities | 30,607 | 17,386 | ||||||
| Stockholders’ Equity (Deficit): | ||||||||
| Preferred stock | — | — | ||||||
| Common stock | 16 | 16 | ||||||
| Additional paid-in capital | 325,350 | 320,937 | ||||||
| Accumulated other comprehensive loss | (1,447 | ) | (391 | ) | ||||
| Accumulated deficit | (176,676 | ) | (151,795 | ) | ||||
| Total stockholders’ equity (deficit) | 147,243 | 168,767 | ||||||
| Total liabilities and stockholders’ equity (deficit) | $ | 177,850 | $ | 186,153 | ||||
| AEYE, INC. Condensed Consolidated Statements of Operations (In thousands, except share and per share data) (Unaudited) | ||||||||
| Three months ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Revenue: | ||||||||
| Prototype sales | $ | 335 | $ | 233 | ||||
| Development contracts | 747 | 96 | ||||||
| Total revenues | 1,082 | 329 | ||||||
| Cost of revenue | 1,482 | 617 | ||||||
| Gross profit (loss) | (400 | ) | (288 | ) | ||||
| Operating Expenses: | ||||||||
| Research and development | 8,576 | 5,836 | ||||||
| Sales and marketing | 4,616 | 1,587 | ||||||
| General and administrative | 11,330 | 3,010 | ||||||
| Total operating expenses | 24,522 | 10,433 | ||||||
| Loss from operations | (24,922 | ) | (10,721 | ) | ||||
| Other income (expense), net: | ||||||||
| Change in fair value of embedded derivative liability and warrant liabilities | (32 | ) | (103 | ) | ||||
| Interest income and other | 424 | 3 | ||||||
| Interest expense and other | (343 | ) | (688 | ) | ||||
| Total other income (expense), net | 49 | (788 | ) | |||||
| Provision for income tax expense | 8 | — | ||||||
| Net loss | $ | (24,881 | ) | $ | (11,509 | ) | ||
| Per Share Data | ||||||||
| Net loss per common share (basic and diluted) | $ | (0.16 | ) | $ | (0.11 | ) | ||
| Weighted average common shares outstanding (basic and diluted) | 155,515,093 | 101,362,036 | ||||||
| AEYE, INC. Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) | ||||||||
| Three Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (24,881 | ) | $ | (11,509 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 208 | 245 | ||||||
| Noncash lease expense relating to operating lease right-of-use assets | 317 | — | ||||||
| Noncash interest expense related to bank loans | — | 114 | ||||||
| Inventory write-downs, net of scrapped inventory | 267 | — | ||||||
| Change in fair value of embedded derivative liability and warrant liabilities | 32 | (17 | ) | |||||
| Stock-based compensation | 5,340 | 1,610 | ||||||
| Amortization of debt issuance costs | — | 283 | ||||||
| Amortization of premiums on marketable securities, net of change in accrued interest | 594 | — | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable, net | 3,930 | (205 | ) | |||||
| Inventories, net | (436 | ) | (235 | ) | ||||
| Prepaid and other current assets | 510 | 332 | ||||||
| Other noncurrent assets | 400 | (2,785 | ) | |||||
| Accounts payable | (567 | ) | 2,494 | |||||
| Accrued expenses and other current liabilities | (645 | ) | 873 | |||||
| Operating lease liabilities | (325 | ) | — | |||||
| Deferred rent | — | (133 | ) | |||||
| Contract liabilities | (767 | ) | 119 | |||||
| Net cash used in operating activities | (16,023 | ) | (8,814 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchase of property and equipment | (774 | ) | (121 | ) | ||||
| Proceeds from redemption of marketable securities | 15,500 | — | ||||||
| Net cash provided by (used in) operating activities | 14,726 | (121 | ) | |||||
| Cash flows from financing activities: | ||||||||
| Proceeds from exercise of stock options | 222 | 85 | ||||||
| Proceeds from the issuance of convertible notes | — | 8,045 | ||||||
| Principal payments - bank loan | — | (333 | ) | |||||
| Taxes paid related to the net share settlement of equity awards | (1,931 | ) | — | |||||
| Net cash provided by (used in) financing activities | (1,709 | ) | 7,797 | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | (3,006 | ) | (1,138 | ) | ||||
| Cash, cash equivalents and restricted cash at beginning of period | 16,333 | 16,497 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 13,327 | $ | 15,359 | ||||
| AEYE, INC. Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands, except share and per share data) (Unaudited) | ||||||||
| Three months ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| GAAP net loss | $ | (24,881 | ) | $ | (11,509 | ) | ||
| Non-GAAP adjustments: | ||||||||
| Stock-based compensation | 5,340 | 1,610 | ||||||
| Change in fair value of embedded derivative and warrant liabilities | 32 | 103 | ||||||
| Non-GAAP net loss | $ | (19,509 | ) | $ | (9,796 | ) | ||
| Depreciation and amortization expense | 208 | 245 | ||||||
| Interest income and other | (424 | ) | (3 | ) | ||||
| Interest expense and other | 343 | 688 | ||||||
| Provision for income tax expense | 8 | — | ||||||
| Adjusted EBITDA | $ | (19,374 | ) | $ | (8,866 | ) | ||
| GAAP net loss per share attributable to common stockholders: | ||||||||
| Basic and diluted | $ | (0.16 | ) | $ | (0.11 | ) | ||
| Non-GAAP net loss per share attributable to common stockholders: | ||||||||
| Basic and diluted | $ | (0.13 | ) | $ | (0.10 | ) | ||
| Shares used in computing GAAP net loss per share attributable to common stockholders: | ||||||||
| Basic and diluted | 155,515,093 | 101,362,036 | ||||||
| Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | ||||||||
| Basic and diluted | 155,515,093 | 101,362,036 | ||||||
Contacts
Media:
Jennifer Deitsch
AEye
jennifer@aeye.ai
925-400-4366
Andie Davis
Landis Communications Inc.
AEye@landispr.com
415-717-9133
Investors:
Clyde Montevirgen
AEye
cmontevirgen@aeye.ai
925-400-4366
Will Stack
Lambert & Co.
AEye@lambert.com
212-971-9718